Transdermal delivery of nicardipine: An approach to in vitro permeation enhancement

Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents

Volumn 9, Issue 4, 2002, Pages 239-247

  Aboofazeli, Reza ^a   Zia, Hossein ^b   Needham, Thomas ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF RHODE ISLAND   (United States)

Author keywords

Cosolvent System; Lecithin Organogel; Microemulsion Based Gel; Nicardipine Free Base; Nicardipine Hydrochloride; Penetration Enhancement; Transdermal Drug Delivery

Indexed keywords

ALCOHOL; BUFFER; DIETHYLENE GLYCOL MONOETHYL ETHER; DIMETHYLISOSORBIDE; ISOSORBIDE DERIVATIVE; MYRISTIC ACID ISOPROPYL ESTER; NICARDIPINE; OLEIC ACID; PHOSPHATIDYLCHOLINE; PROPYLENE GLYCOL; UNCLASSIFIED DRUG; SOLVENT;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG PENETRATION; DRUG SOLUBILITY; GEL; GUINEA PIG; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERTENSION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; SKIN PERMEABILITY; STABLE ANGINA PECTORIS; STRATUM CORNEUM; ANIMAL; CHEMISTRY; DRUG EFFECT; HUMAN; INTRADERMAL DRUG ADMINISTRATION; METABOLISM; METHODOLOGY; PERMEABILITY; SKIN;

ADMINISTRATION, CUTANEOUS; ANIMALS; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; GUINEA PIGS; HUMANS; NICARDIPINE; PERMEABILITY; SKIN; SOLVENTS;

EID: 0036812998     PISSN: 10717544     EISSN: None     Source Type: Journal    
DOI: 10.1080/10717540260397855     Document Type: Article

References (25)

1. Bhatnagar, S., and Vyas, S. P. 1994. Organogel-based system for transdermal delivery of propranolol. J. Microencapsulation 11:431-438.
2. Curdy, C., Kalia, Y. N., and Guy, R. H. 2001. Noninvasive assessment of the effects of iontophoresis on human skin in vivo. J. Pharm. Pharmacol. 53:769-777.
3. Diez, I., Colom, H., Moreno, J., Obach, R., Peraire, C., and Domenech, J. 1991. A comparative in vitro study of transdermal absorption of a series of calcium channel antagonists. J. Pharm. Sci. 80:931-934.
4. Dreher, F., Walde, P., Luisi, P. L., and Elsner, P. 1996. Human skin irritation studies of a lecithin microemulsion gel and of lecithin liposomes. Skin Pharmacol. 9:124-129.
5. Dreher, F., Walde, P., Walther, P., and Werhrli, E. 1997. Interaction of lecithin microemulsion gel with human stratum corneum and its effect on transdermal transport. J. Contr. Rel. 45:131-140.
6. Frishman, W. H. 1989. New therapeutic modalities in hypertension: Focus on a new calcium antagonist-nicardipine. J. Clin. Pharmacol. 29:481-487.
7. Guy, R. H. 1998. Iontophoresis - Recent developments. J. Pharm. Pharmacol. 50:371-374.
8. Higuchi, T. 1960. J. Soc. Cosmet. Chem. 11:85. Cited by Seki, T., Sugibayashi, K., and Morimoto, Y. 1987. Effect of solvents on the permeation of nicardipine hydrochloride through the hairless rat skin. Chem. Pharm. Bull. 35:3054-3057.
9. Higuchi, T. 1960. J. Soc. Cosmet. Chem. 11:85. Cited by Seki, T., Sugibayashi, K., and Morimoto, Y. 1987. Effect of solvents on the permeation of nicardipine hydrochloride through the hairless rat skin. Chem. Pharm. Bull. 35:3054-3057.
10. Kou, J. H., Roy, S. D., Du, J., and Fujiki, J. 1993. Effect of receiver fluid pH on in vitro skin flux of weekly ionizable drugs. Pharm. Res. 10:986-990.
11. Mitragorti, S., and Kost, J. 2000. Low frequency sonophoresis: A noninvasive method of drug delivery and diagnostics. Biotechnol. Progr. 16:488-492.
12. Mitragorti, S., Edwards, D. A., Blankschtein, D., and Langer, R. 1995. A mechanistic study of ultrasonically-enhanced transdermal drug delivery. J. Pharm. Sci. 84:697-706.
13. Potts, R. O., Mak, V. H. W., Guy, R. H., and Francoeur, M. L. 1991. Advance. Lipid Res. 24:173-210.
14. Scartazzini, R., and Luisi, P. L. 1988. Organogels from lecithin. J. Phys. Chem. 92:829-833.
15. Schurtenberger, P., Scartazzini, R., Majid, L. J., Leser, M. E., and Luisi, P. L. 1990. Structural and dynamic properties of polymer-like reverse micelles. J. Phys. Chem. 94:3695-3701.
16. Seki, T., Sugibayashi, K., and Morimoto, Y. 1987. Effect of solvents on the permeation of nicardipine hydrochloride through the hairless rat skin. Chem. Pharm. Bull. 35:3054-3057.
17. Seki, T., Sugibayashi, K., Juni, K., and Morimoto, Y. 1989. Percutaneous absorption enhancer applied to membrane permeation-controlled trandermal delivery of nicardipine hydrochloride. Drug Des. Develop. 4:69-75.
18. Singh, S. K., Durrani, M. J., Reddy, I. K., and Khan, M. A. 1996. Effect of permeation enhancers on the release of ketoprofen through transdermal drug delivery systems. Pharmazie 51:741-744.
19. Sinha, V. R., and Kaur, M. P. 2000. Permeation enhancers for transdermal drug delivery. Drug Develop. Ind. Pharm. 26:1131-1140.
20. Sorkin, E. M., and Clissold, S. P. 1987. Nicardipine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardivascular disorders. Drugs 33:296-345.
21. Squillante, E., Maniar, A., Needham, T. E., and Zia, H. 1998. Optimization of in vitro nifedipine enhancement through hairless mouse skin. Int. J. Pharm. 169:143-154.
22. Squillante, E., Nanda, A., Needham, T. E., and Zia, H. 2000. Transdermal delivery of calcium channel blockers, such as nifedipine. U.S. Patent 6,106,856.
23. Squillante, E., Needham, T. E., Maniar, A., Kislalioglu, S., and Zia, H. 1998. Codiffusion of propylene glycol and dimethyl isosorbide in hairless mouse skin. Eur. J. Pharm. Biopharm. 46:265-271.
24. Willimann, H., Walde, P., Luisi, P. L., Gazzaniga, A., and Stropollo, F. 1992. Lecithin organogels as matrix for transdermal transport of drugs. J. Pharm. Sci. 81:871-874.
25. Yu, D., Sanders, L. M., Davidson, III, G. W. R., Marvin, M. J., and Ling, T. 1988. Percutaneous absorption of nicardipine and ketorolac in rhesus monkey. Pharm. Res. 5:457-461.